MeiraGTx Holdings plc Deal History & Licensing Activity
MeiraGTx Holdings plc is a life sciences. Over the past three years, MeiraGTx Holdings plc has been involved in 1 licensing and acquisition transaction, with a primary focus on Gene Therapy (2 deals).
Deals (12mo)
1
Active Trials
0
Top Modality
Gene Therapy
Focus Area
Ophthalmology
MeiraGTx Holdings plc Recent Deal Activity
Licensing, acquisition, and partnership transactions involving MeiraGTx Holdings plc in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| botaretigene sparoparvovec (bota-vec) | Johnson & Johnson | Gene Therapy | Phase 3 | acquisition | Apr 2026 |
MeiraGTx Holdings plc Pipeline Focus
Therapeutic areas and modalities where MeiraGTx Holdings plc is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
See How Your Asset Matches MeiraGTx Holdings plc's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Ophthalmology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Ophthalmology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for ophthalmology
Gene Therapy Benchmarks
Upfront, milestone, and royalty benchmarks for gene therapy deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About MeiraGTx Holdings plc Licensing & Deal Activity
MeiraGTx Holdings plc is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, MeiraGTx Holdings plc ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for MeiraGTx Holdings plc include Ophthalmology (2 deals and trials). In terms of modality, MeiraGTx Holdings plc has shown particular interest in gene therapy.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for MeiraGTx Holdings plc and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against MeiraGTx Holdings plc's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.